Evidence map›Paper›PMID 40691767›Full record

ArticleBMC medical imaging2025

The value of habitat analysis based on

Yang Wang, Hongyue Zhao, Zhehao Lyu, Linhan Zhang, Wei Han, Zeyu Wang, Jiafu Wang, Xinyue Zhang, Shibo Guo, Peng Fu and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yang WangDepartment of Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province, China.
Hongyue ZhaoDepartment of Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province, China.
Zhehao LyuDepartment of Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province, China.
Linhan ZhangDepartment of Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province, China.
Wei HanDepartment of Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province, China.
Zeyu WangDepartment of Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province, China.
Jiafu WangDepartment of Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province, China.
Xinyue ZhangDepartment of Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province, China.
Shibo GuoDepartment of Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province, China.
Peng FuDepartment of Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province, China.
Changjiu ZhaoDepartment of Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province, China. 13904606820@163.com.

Funding

Research and innovation fund of the First Affiliated Hospital of Harbin Medical University 2024M22
6 · The paper itself

Abstract

purposeTo evaluate the performance of habitat analysis by positron emission tomography (PET)/computed tomography (CT) with

methodsThe data of 42 PCa patients who underwent

resultsSUV

conclusionThe results of this pilot study showed that the combined prediction model, as a non-invasive method, may provide additional value for risk stratification of PCa, offering new perspectives for individualized clinical diagnosis and treatment.

trial registrationhttps://www.chictr.org.cn/ .

trial registrationRegistration number: ChiCTR2100052238 (retrospectively registered).

Indexed as

OligopeptidesPositron Emission Tomography Computed TomographyProstatic NeoplasmsAgedHumansMaleMiddle AgedNeoplasm GradingNiacinamideRadiopharmaceuticalsRetrospective StudiesRisk FactorsROC CurveSensitivity and SpecificityNiacinamideOligopeptidesPSMA-1007RadiopharmaceuticalsGleason scoreHabitat analysisPositron emission tomography-computed tomographyProstate cancerProstate-specific membrane antigen

Identifiers

PMID40691767
PMCPMC12281703

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.